Exosomes for targeted siRNA delivery across biological barriers

被引:414
|
作者
EL Andaloussi, Samir [1 ]
Lakhal, Samira [1 ]
Maeger, Imre [1 ]
Wood, Matthew J. A. [1 ]
机构
[1] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England
关键词
Blood-brain barrier; Exosomes; Membrane vesicles; Microvesicles; Micro RNA; RNA interference; siRNA; CELL-DERIVED EXOSOMES; LIPID-LIKE MATERIALS; DOUBLE-STRANDED-RNA; MESSENGER-RNA; ENDOTHELIAL-CELLS; MULTIVESICULAR ENDOSOMES; INTERCELLULAR TRANSFER; HORIZONTAL TRANSFER; MAMMALIAN-CELLS; TUMOR-CELLS;
D O I
10.1016/j.addr.2012.08.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Using oligonucleotide-based drugs to modulate gene expression has opened a new avenue for drug discovery. In particular small interfering RNAs (siRNAs) are being rapidly recognized as promising therapeutic tools, but their poor bioavailability limits the full realization of their clinical potential. In recent years, cumulating evidence has emerged for the role of membrane vesicles, secreted by most cells and found in all body fluids, as key mediators of information transmission between cells. Importantly, a sub-group of these termed exosomes, have recently been shown to contain various RNA species and to mediate their horizontal transfer to neighbouring- or distant recipient cells. Here, we provide a brief overview on membrane vesicles and their role in exchange of genetic information. We also describe how these natural carriers of genetic material can be harnessed to overcome the obstacle of poor delivery and allow efficient systemic delivery of exogenous siRNA across biological barriers such as the blood-brain barrier. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:391 / 397
页数:7
相关论文
共 50 条
  • [41] Knocking down barriers: advances in siRNA delivery
    Whitehead, Kathryn A.
    Langer, Robert
    Anderson, Daniel G.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (02) : 129 - 138
  • [42] Knocking down barriers: advances in siRNA delivery
    Kathryn A. Whitehead
    Robert Langer
    Daniel G. Anderson
    [J]. Nature Reviews Drug Discovery, 2009, 8 : 129 - 138
  • [43] Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
    Juliano, R.
    Bauman, J.
    Kang, H.
    Ming, X.
    [J]. MOLECULAR PHARMACEUTICS, 2009, 6 (03) : 686 - 695
  • [44] Targeted siRNA delivery to myeloid precursor cells
    Beyerle, A.
    Rueger, R.
    Scholz, A.
    Kontermann, R.
    Heidenreich, O.
    [J]. KLINISCHE PADIATRIE, 2011, 223 (03): : 200 - 200
  • [45] Ribonucleoprotein: A Biomimetic Platform for Targeted siRNA Delivery
    Tai, Wanyi
    Gao, Xiaohu
    [J]. ADVANCED FUNCTIONAL MATERIALS, 2019, 29 (35)
  • [46] Ligand-Targeted Delivery of Therapeutic siRNA
    Yutaka Ikeda
    Kazunari Taira
    [J]. Pharmaceutical Research, 2006, 23 : 1631 - 1640
  • [47] Polyethylenimine as a Promising Vector for Targeted siRNA Delivery
    Nimesh, Surendra
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2012, 7 (02): : 121 - 130
  • [48] Targeted delivery of siRNA to macrophages and microglia cells
    Swamy, Manjunath N.
    [J]. JOURNAL OF NEUROVIROLOGY, 2010, 16 : 85 - 85
  • [49] Strategies and advances in nanomedicine for targeted siRNA delivery
    Nimesh, Surendra
    Gupta, Nidhi
    Chandra, Ramesh
    [J]. NANOMEDICINE, 2011, 6 (04) : 729 - 746
  • [50] Progress in targeted delivery of siRNA to combat Coxsackievirus
    Gautam, Anju
    [J]. PROTEIN & CELL, 2011, 2 (11) : 855 - 857